Effectiveness of hypoxia-induced factor prolyl hydroxylase inhibitor for managing anemia in chronic kidney disease: a systematic review and meta-analysis
ConclusionThe current meta-analysis recommends the use of hypoxia-induced factor prolyl hydroxylase inhibitor for managing anemia in chronic kidney disease.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Academia | Anemia | Chronic Kidney Disease | Databases & Libraries | Dialysis | Drugs & Pharmacology | Hemodialysis | Statistics | Urology & Nephrology